Regulations on Herbal Products in India, United States and European Union: A Review

Herbal products are now being mainstay of about 80% of the world population for primary health care. The belief that herbs are safe is not completely true, as many cases of untoward effects are observed following their imprudent use. Therefore, we need to have regulative measures on herbal products...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International Journal of Drug Regulatory Affairs 2022-06, Vol.10 (2), p.67-72
Hauptverfasser: Sapoliya, Nirav Kumar, Mamta B Shah
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 72
container_issue 2
container_start_page 67
container_title International Journal of Drug Regulatory Affairs
container_volume 10
creator Sapoliya, Nirav Kumar
Mamta B Shah
description Herbal products are now being mainstay of about 80% of the world population for primary health care. The belief that herbs are safe is not completely true, as many cases of untoward effects are observed following their imprudent use. Therefore, we need to have regulative measures on herbal products that would keep check on each step of entire process of drug development. Ensuring efficacy and safety of these products is going to increase the global acceptance and would be serving a greater number of populations worldwide in an inculpable manner. Working in this direction almost every country has developed their plan of work for regulation of herbal products that are referred as traditional medicines, alternative medicines, complimentary medicines, natural health product, health supplements etc. Electronic review method was used to compile information for this review on the regulation of herbal product around the world in this study. The data were collected from different databases such as Google scholar, ResearchGate, PubMed, pharma tutor, and etc.
doi_str_mv 10.22270/ijdra.v10i2.528
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_22270_ijdra_v10i2_528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_22270_ijdra_v10i2_528</sourcerecordid><originalsourceid>FETCH-LOGICAL-c888-d1f6fb1c5a45b1f221aad3800a8f49f4087d095e4b7d8a9a7d3b709427e149263</originalsourceid><addsrcrecordid>eNot0MFLwzAYBfAgCo65u8f8AXYmX9Mm9TbGdIOBss1z-dokEqnJSNqJ_72u7vQePHiHHyH3nM0BQLJH96kjzk-cOZgXoK7IBHLgWSkrcX3pkpdwS2YpuYblJRRclnJC9jvzMXTYu-ATDZ6uTWywo28x6KHtE3Webrx2-EDfveuNpvsee5Moek1XQwxHg_48Bf9EF3RnTs5835Ebi10ys0tOyeF5dVius-3ry2a52GatUirT3Ja24W2Bomi4BeCIOleMobKisoIpqVlVGNFIrbBCqfNGskqANFxUUOZTwv5v2xhSisbWx-i-MP7UnNUjSz2y1CNL_ceS_wI2k1bf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Regulations on Herbal Products in India, United States and European Union: A Review</title><source>EZB Electronic Journals Library</source><creator>Sapoliya, Nirav Kumar ; Mamta B Shah</creator><creatorcontrib>Sapoliya, Nirav Kumar ; Mamta B Shah</creatorcontrib><description>Herbal products are now being mainstay of about 80% of the world population for primary health care. The belief that herbs are safe is not completely true, as many cases of untoward effects are observed following their imprudent use. Therefore, we need to have regulative measures on herbal products that would keep check on each step of entire process of drug development. Ensuring efficacy and safety of these products is going to increase the global acceptance and would be serving a greater number of populations worldwide in an inculpable manner. Working in this direction almost every country has developed their plan of work for regulation of herbal products that are referred as traditional medicines, alternative medicines, complimentary medicines, natural health product, health supplements etc. Electronic review method was used to compile information for this review on the regulation of herbal product around the world in this study. The data were collected from different databases such as Google scholar, ResearchGate, PubMed, pharma tutor, and etc.</description><identifier>ISSN: 2321-7162</identifier><identifier>EISSN: 2321-6794</identifier><identifier>DOI: 10.22270/ijdra.v10i2.528</identifier><language>eng</language><ispartof>International Journal of Drug Regulatory Affairs, 2022-06, Vol.10 (2), p.67-72</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c888-d1f6fb1c5a45b1f221aad3800a8f49f4087d095e4b7d8a9a7d3b709427e149263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Sapoliya, Nirav Kumar</creatorcontrib><creatorcontrib>Mamta B Shah</creatorcontrib><title>Regulations on Herbal Products in India, United States and European Union: A Review</title><title>International Journal of Drug Regulatory Affairs</title><description>Herbal products are now being mainstay of about 80% of the world population for primary health care. The belief that herbs are safe is not completely true, as many cases of untoward effects are observed following their imprudent use. Therefore, we need to have regulative measures on herbal products that would keep check on each step of entire process of drug development. Ensuring efficacy and safety of these products is going to increase the global acceptance and would be serving a greater number of populations worldwide in an inculpable manner. Working in this direction almost every country has developed their plan of work for regulation of herbal products that are referred as traditional medicines, alternative medicines, complimentary medicines, natural health product, health supplements etc. Electronic review method was used to compile information for this review on the regulation of herbal product around the world in this study. The data were collected from different databases such as Google scholar, ResearchGate, PubMed, pharma tutor, and etc.</description><issn>2321-7162</issn><issn>2321-6794</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNot0MFLwzAYBfAgCo65u8f8AXYmX9Mm9TbGdIOBss1z-dokEqnJSNqJ_72u7vQePHiHHyH3nM0BQLJH96kjzk-cOZgXoK7IBHLgWSkrcX3pkpdwS2YpuYblJRRclnJC9jvzMXTYu-ATDZ6uTWywo28x6KHtE3Webrx2-EDfveuNpvsee5Moek1XQwxHg_48Bf9EF3RnTs5835Ebi10ys0tOyeF5dVius-3ry2a52GatUirT3Ja24W2Bomi4BeCIOleMobKisoIpqVlVGNFIrbBCqfNGskqANFxUUOZTwv5v2xhSisbWx-i-MP7UnNUjSz2y1CNL_ceS_wI2k1bf</recordid><startdate>20220619</startdate><enddate>20220619</enddate><creator>Sapoliya, Nirav Kumar</creator><creator>Mamta B Shah</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220619</creationdate><title>Regulations on Herbal Products in India, United States and European Union: A Review</title><author>Sapoliya, Nirav Kumar ; Mamta B Shah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c888-d1f6fb1c5a45b1f221aad3800a8f49f4087d095e4b7d8a9a7d3b709427e149263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Sapoliya, Nirav Kumar</creatorcontrib><creatorcontrib>Mamta B Shah</creatorcontrib><collection>CrossRef</collection><jtitle>International Journal of Drug Regulatory Affairs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sapoliya, Nirav Kumar</au><au>Mamta B Shah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulations on Herbal Products in India, United States and European Union: A Review</atitle><jtitle>International Journal of Drug Regulatory Affairs</jtitle><date>2022-06-19</date><risdate>2022</risdate><volume>10</volume><issue>2</issue><spage>67</spage><epage>72</epage><pages>67-72</pages><issn>2321-7162</issn><eissn>2321-6794</eissn><abstract>Herbal products are now being mainstay of about 80% of the world population for primary health care. The belief that herbs are safe is not completely true, as many cases of untoward effects are observed following their imprudent use. Therefore, we need to have regulative measures on herbal products that would keep check on each step of entire process of drug development. Ensuring efficacy and safety of these products is going to increase the global acceptance and would be serving a greater number of populations worldwide in an inculpable manner. Working in this direction almost every country has developed their plan of work for regulation of herbal products that are referred as traditional medicines, alternative medicines, complimentary medicines, natural health product, health supplements etc. Electronic review method was used to compile information for this review on the regulation of herbal product around the world in this study. The data were collected from different databases such as Google scholar, ResearchGate, PubMed, pharma tutor, and etc.</abstract><doi>10.22270/ijdra.v10i2.528</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2321-7162
ispartof International Journal of Drug Regulatory Affairs, 2022-06, Vol.10 (2), p.67-72
issn 2321-7162
2321-6794
language eng
recordid cdi_crossref_primary_10_22270_ijdra_v10i2_528
source EZB Electronic Journals Library
title Regulations on Herbal Products in India, United States and European Union: A Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A41%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulations%20on%20Herbal%20Products%20in%20India,%20United%20States%20and%20European%20Union:%20A%20Review&rft.jtitle=International%20Journal%20of%20Drug%20Regulatory%20Affairs&rft.au=Sapoliya,%20Nirav%20Kumar&rft.date=2022-06-19&rft.volume=10&rft.issue=2&rft.spage=67&rft.epage=72&rft.pages=67-72&rft.issn=2321-7162&rft.eissn=2321-6794&rft_id=info:doi/10.22270/ijdra.v10i2.528&rft_dat=%3Ccrossref%3E10_22270_ijdra_v10i2_528%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true